New coronavirus infection COVID-19 as a trigger for the development of symptoms of ankylosing spondylitis. Case report

Cover Page

Cite item

Full Text

Abstract

The novel coronavirus infection COVID-19 (SARS-CoV-2) is now known to cause a variety of extrapulmonary complications, including cardiovascular, neurological and dermatological complications, many of which occur or last several weeks after infection. We present a clinical case of a patient who first developed symptoms of ankylosing spondylitis 2 weeks after recovering from COVID-19. The patient was prescribed therapy in accordance with international and Russian recommendations for the management of patients with ankylosing spondylitis with a positive effect in the form of absence arthritis, enthesitis and reducing the inflammatory back pain.

About the authors

Daria G. Rumiantceva

Nasonova Research Institute of Rheumatology

Author for correspondence.
Email: rumiantceva01@gmail.com
ORCID iD: 0000-0002-1684-1213

канд. мед. наук, мл. науч. сотр. лаб. спондилоартритов и псориатического артрита

Russian Federation, Moscow

Margarita M. Urumova

Nasonova Research Institute of Rheumatology

Email: rumiantceva01@gmail.com
ORCID iD: 0000-0002-9755-5760

канд. мед. наук, зав. 2-м ревматологическим отд-нием

Russian Federation, Moscow

Shandor F. Erdes

Nasonova Research Institute of Rheumatology

Email: rumiantceva01@gmail.com
ORCID iD: 0000-0003-3195-5187

д-р мед. наук, проф., вед. науч. сотр. лаб. спондилоартритов и псориатического артрита

Russian Federation, Moscow

References

  1. Wang H, Li X, Li T, et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020;39(9):1629-35. doi: 10.1007/s10096-020-03899-4
  2. WHO Coronavirus (COVID-19) Dashboard. Available: https://covid19.who.int. Accessed: 05.05.2021.
  3. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568-76. doi: 10.1002/jmv.25748
  4. Guan WJ, Zhong NS. Clinical characteristics of Covid-19 in China. N Engl J Med. 2020;382(19):1861–2. doi: 10.1056/nejmc2005203
  5. Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):a multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80:388-93. doi: 10.1016/j.jinf.2020.02.016
  6. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-13. doi: 10.1016/s0140-6736(20)30211-7
  7. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-Infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-9. doi: 10.1001/jama.2020.1585
  8. Xie HT, Jiang SY, Xu KK, et al. SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye Vis (Lond). 2020;7:23. doi: 10.1186/s40662-020-00189-0
  9. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):1-9. doi: 10.1001/jamaneurol.2020.1127
  10. Wang L, Wang Y, Ye D, et al. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020;55:105948. doi: 10.1016/j.ijantimicag.2020.105948 11. Ono K, Kishimoto M, Shimasaki T, et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020;6:e001350. doi: 10.1136/rmdopen-2020-001350
  11. Эрдес Ш.Ф., Бадокин В.В., Бочкова А.Г., и др. О терминологии спондилоартритов. Научно-практическая ревматология. 2015;53(6):657-60 [Erdes SF, Badokin VV, Bochkova AG, et al. On the terminology of spondyloarthritis. Rheumatology Science and Practice. 2015;53(6):657-60 (in Russian)]. doi: 10.14412/1995-4484-2015-657-660
  12. Wan S, Yi Q, Fan S, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv. 2020. doi: 10.1101/2020.02.10.20021832
  13. Насонов Е.Л. Иммунопатология и иммунофармакотерапия коронавирусной болезни 2019 (COVID-19): фокус на интерлейкин 6. Научно- практическая ревматология. 2020;58(3):245-61 [Nasonov EL. Immunopathology and immunopharmacotherapy of coronavirus disease 2019 (COVID-19): focus on interleukin 6. Rheumatology Science and Practice. 2020;58(3):245-61 (in Russian)]. doi: 10.14412/1995-4484-2020-245-261
  14. Liu Y, Zhang C, Huang F, et al. Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury. Nat Sci Rev. 2020:nwaa037. doi: 10.1093/nsr/nwaa037
  15. Liu J, Li S, Liu J, et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. X-ray of pelvic bones.

Download (66KB)
Indexing metadata
3. Fig. 2. SIJ MRI in STIR and T1 mode (axial slice). The arrow indicates bone tissue edema

Download (48KB)
Indexing metadata

Copyright (c) 2021 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies